White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies

MT newswire2026/09/01 09:57

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

05:57 AM EDT, 09/01/2026 (MT Newswires) -- The White House made nine new agreements with pharmaceutical manufacturers to bring prescription drug prices for Americans down to the lowest prices paid by other developed nations, it said on Monday. The nine manufacturers include Teva Pharmaceuticals (TEVA), BridgeBio (BBIO), Alcon (ALC), BeOne Medicines (ONC), Astellas Pharma, CSL, Kyowa Kirin, Sun Pharma, and UCB, the White House said. The drugs include treatments for hemophilia, Parkinson's disease, macular degeneration, glaucoma, liver disease, skin conditions, and various forms of cancers, the White House said.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

The U.S. Energy Information Administration (EIA) has raised its forecast for average Brent crude oil prices in 2026 and 2027 to $97 and $86, respectively, reflecting pressures from global inventory declines, Middle East supply disruptions, and rising transportation costs. As oil production in the Middle East gradually recovers and global inventories rebound from low levels, the EIA expects the average spot price of Brent crude to fall to $87 per barrel in the second quarter of 2027, and further decline to $77 per barrel by the fourth quarter.

华尔街见闻•2026/11/10 18:41